Koyfin Home > Directory > Health Care > Rhythm Pharmaceuticals Inc > Cost of Goods Sold

Rhythm Pharmaceuticals Inc Cost of Goods Sold Chart (RYTM)

Rhythm Pharmaceuticals Inc annual/quarterly Cost of Goods Sold from 2019 to 2019.
Other Income Statement Metrics:
  • Rhythm Pharmaceuticals Inc EBITDA for the quarter ending December 12, 2018 was $-27m a 37.36% decrease of -10m year over year
  • Rhythm Pharmaceuticals Inc Net Income for the quarter ending September 09, 2018 was $-18m a 40.46% decrease of -7m year over year
View Chart On Koyfin